Glenmark Gets USFDA Nod to Expand RYALTRIS Use
Glenmark touched a day’s high of Rs 2,249.30 on the NSE on Tuesday, after the USFDA approved a wider use of its allergy spray RYALTRIS....
Tag : Glenmark Pharmaceuticals
Glenmark Pharma Shares Soared 7% on Successfully Clearing USFDA Inspection
Shares of Glenmark Pharmaceuticals Ltd soared 7% on 23 September after the company’s manufacturing facility in Aurangabad successfully cleared the US Food and Drug Administration’s...
Glenmark Receives USFDA Final Approval for Topiramate Capsules
Glenmark Pharmaceuticals has received final approval from the United States Food & Drug Administration (USFDA) for its Topiramate Capsules USP, 15 mg and 25 mg,...
Glenmark Pharma’s Shares Surge as Unit bags Licensing pact to sell Cancer Drugs
Glenmark Pharmaceuticals shares climbed more than 2% in the early trading hours on Thursday after the pharma company announced that its subsidiary, Glenmark Specialty S...
Glenmark Shares Surge as USFDA Grants Approval for Generic Drug Used to Treat Certain Mental Disorders
Shares of Glenmark Pharmaceuticals Ltd rallied over 2% as the company received final approval from the United States Food & Drug Administration (US FDA) for...
Glenmark Announces the Launch of Combination Diabetes Drug
Pharmaceutical major Glenmark Pharma, on 18 October, announced the launch of a Triple-drug FDC (fixed drug combination) of Teneligliptin + Dapagliflozin + Metformin in India...
Glenmark Pharmaceuticals Gets USFDA Approval to Market its Drug
The Mumbai-based drug maker Glenmark Pharmaceuticals on 1 August said it had received the nod from the US Food and Drug Administration (USFDA) to market...
Glenmark Pharma Signs Settlement Agreement with Pfizer Over Cancer Drug
On Tuesday, Glenmark Pharmaceuticals said it had reached a settlement with Pfizer over a cancer treatment drug.The Mumbai-based drugmaker and its US subsidiary signed a...
Nifty Drops Below 18,250 Level
In the domestic market, barometers extended losses and hit fresh trade low in the morning trade. The Nifty traded tad below the 18,250 level. Also,...
Glenmark Pharma Launches Drug to Treat Type 2 Diabetes in Adults
Glenmark Pharmaceuticals announced on October 6 that it had become the first company in India to launch thiazolidinedione (lobeglitazone) for adults with type 2 diabetes....